{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T13:32:09Z","timestamp":1793021529374,"version":"4.5.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>The proliferation of bladder cancer (BC) cells is driven by metabolic reprogramming, marked by a glycolytic dependency to sustain uncontrolled growth. While Transforming Acidic Coiled-Coil Containing Protein 3 (TACC3) is known to promote BC progression and correlate with poor prognosis, the mechanisms underlying its upregulation and role in aerobic glycolysis remain unclear. Here, we identify E2F3 as a direct transcriptional activator of <jats:italic>TACC3<\/jats:italic>, with its amplification in BC driving elevated TACC3 expression. TACC3 overexpression enhances glycolysis, increasing glucose consumption, lactate production, and expression of glycolytic enzymes (e.g., GLUT1, HK2, PFKFB3), while its knockdown suppresses these effects. Pharmacological inhibition of glycolysis abrogates TACC3-driven tumor growth in vitro and in vivo. Mechanistically, TACC3 interacts with c-Myc, promoting its acetylation at lysine 323 (K323) by recruiting the acetyltransferase PCAF and antagonizing the deacetylase SIRT1. This acetylation stabilizes c-Myc, amplifying its transcriptional activation of glycolytic targets. Our findings establish TACC3 as a critical regulator of c-Myc-driven metabolic reprogramming in BC, highlighting its potential as a therapeutic target to disrupt glycolysis and oncogenic c-Myc signaling.<\/jats:p>","DOI":"10.1038\/s41419-025-07645-6","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T14:23:32Z","timestamp":1744899812000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["TACC3 enhances glycolysis in bladder cancer cells through inducing acetylation of c-Myc"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-5340-0574","authenticated-orcid":false,"given":"Zhirui","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Falian","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gengde","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xizhen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,17]]},"reference":[{"key":"7645_CR1","doi-asserted-by":"crossref","unstructured":"Faubert B, Solmonson A, DeBerardinis RJ. Metabolic reprogramming and cancer progression. Science. 2020;368:eaaw5473.","DOI":"10.1126\/science.aaw5473"},{"key":"7645_CR2","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374.","journal-title":"Cell"},{"key":"7645_CR3","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrc3038","volume":"11","author":"WH Koppenol","year":"2011","unstructured":"Koppenol WH, Bounds PL, Dang CV. Otto Warburg\u2019s contributions to current concepts of cancer metabolism. Nat Rev Cancer. 2011;11:325\u201337.","journal-title":"Nat Rev Cancer"},{"key":"7645_CR4","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41573-021-00339-6","volume":"21","author":"ZE Stine","year":"2022","unstructured":"Stine ZE, Schug ZT, Salvino JM, Dang CV. Targeting cancer metabolism in the era of precision oncology. Nat Rev Drug Discov. 2022;21:141\u201362.","journal-title":"Nat Rev Drug Discov"},{"key":"7645_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-9-33","volume":"9","author":"M Zhou","year":"2010","unstructured":"Zhou M, Zhao Y, Ding Y, Liu H, Liu Z, Fodstad O, et al. Warburg effect in chemosensitivity: targeting lactate dehydrogenase-A re-sensitizes taxol-resistant cancer cells to taxol. Mol Cancer. 2010;9:33.","journal-title":"Mol Cancer"},{"key":"7645_CR6","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1158\/0008-5472.CAN-11-3928","volume":"72","author":"G Cheng","year":"2012","unstructured":"Cheng G, Zielonka J, Dranka BP, McAllister D, Mackinnon AC Jr., Joseph J, et al. Mitochondria-targeted drugs synergize with 2-deoxyglucose to trigger breast cancer cell death. Cancer Res. 2012;72:2634\u201344.","journal-title":"Cancer Res"},{"key":"7645_CR7","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1101\/gad928101","volume":"15","author":"RN Eisenman","year":"2001","unstructured":"Eisenman RN. Deconstructing myc. Genes Dev. 2001;15:2023\u201330.","journal-title":"Genes Dev"},{"key":"7645_CR8","doi-asserted-by":"publisher","first-page":"6479","DOI":"10.1158\/1078-0432.CCR-09-0889","volume":"15","author":"CV Dang","year":"2009","unstructured":"Dang CV, Le A, Gao P. MYC-induced cancer cell energy metabolism and therapeutic opportunities. Clin Cancer Res. 2009;15:6479\u201383.","journal-title":"Clin Cancer Res"},{"key":"7645_CR9","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/nature08697","volume":"463","author":"CJ David","year":"2010","unstructured":"David CJ, Chen M, Assanah M, Canoll P, Manley JL. HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer. Nature. 2010;463:364\u20138.","journal-title":"Nature"},{"key":"7645_CR10","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41571-023-00744-3","volume":"20","author":"LMC van Hoogstraten","year":"2023","unstructured":"van Hoogstraten LMC, Vrieling A, van der Heijden AG, Kogevinas M, Richters A, Kiemeney LA. Global trends in the epidemiology of bladder cancer: challenges for public health and clinical practice. Nat Rev Clin Oncol. 2023;20:287\u2013304.","journal-title":"Nat Rev Clin Oncol"},{"key":"7645_CR11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41571-023-00826-2","volume":"21","author":"R Nadal","year":"2024","unstructured":"Nadal R, Valderrama BP, Bellmunt J. Progress in systemic therapy for advanced-stage urothelial carcinoma. Nat Rev Clin Oncol. 2024;21:8\u201327.","journal-title":"Nat Rev Clin Oncol"},{"key":"7645_CR12","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.cell.2017.09.007","volume":"171","author":"AG Robertson","year":"2017","unstructured":"Robertson AG, Kim J, Al-Ahmadie H, Bellmunt J, Guo G, Cherniack AD, et al. Comprehensive molecular characterization of muscle-invasive bladder cancer. Cell. 2017;171:540\u201356.e25.","journal-title":"Cell"},{"key":"7645_CR13","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/nature12965","volume":"507","author":"Cancer Genome Atlas Research N.","year":"2014","unstructured":"Cancer Genome Atlas Research N. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014;507:315\u201322.","journal-title":"Nature"},{"key":"7645_CR14","doi-asserted-by":"publisher","first-page":"31719","DOI":"10.1074\/jbc.M114.575100","volume":"289","author":"P Singh","year":"2014","unstructured":"Singh P, Thomas GE, Gireesh KK, Manna TK. TACC3 protein regulates microtubule nucleation by affecting gamma-tubulin ring complexes. J Biol Chem. 2014;289:31719\u201335.","journal-title":"J Biol Chem"},{"key":"7645_CR15","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/onc.2010.431","volume":"30","author":"AB Fielding","year":"2011","unstructured":"Fielding AB, Lim S, Montgomery K, Dobreva I, Dedhar S. A critical role of integrin-linked kinase, ch-TOG and TACC3 in centrosome clustering in cancer cells. Oncogene. 2011;30:521\u201334.","journal-title":"Oncogene"},{"key":"7645_CR16","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.tcb.2008.06.005","volume":"18","author":"I Peset","year":"2008","unstructured":"Peset I, Vernos I. The TACC proteins: TACC-ling microtubule dynamics and centrosome function. Trends Cell Biol. 2008;18:379\u201388.","journal-title":"Trends Cell Biol"},{"key":"7645_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-017-0112-6","volume":"9","author":"ZR Lin","year":"2018","unstructured":"Lin ZR, Wang MY, He SY, Cai ZM, Huang WR. TACC3 transcriptionally upregulates E2F1 to promote cell growth and confer sensitivity to cisplatin in bladder cancer. Cell Death Dis. 2018;9:72.","journal-title":"Cell Death Dis"},{"key":"7645_CR18","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1097\/PAI.0000000000000392","volume":"26","author":"H Song","year":"2018","unstructured":"Song H, Liu C, Shen N, Yi P, Dong F, Li X, et al. Overexpression of TACC3 in breast cancer associates with poor prognosis. Appl Immunohistochem Mol Morphol. 2018;26:113\u20139.","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"7645_CR19","doi-asserted-by":"publisher","first-page":"6850","DOI":"10.18632\/oncotarget.3190","volume":"6","author":"ZL Huang","year":"2015","unstructured":"Huang ZL, Lin ZR, Xiao YR, Cao X, Zhu LC, Zeng MS, et al. High expression of TACC3 in esophageal squamous cell carcinoma correlates with poor prognosis. Oncotarget. 2015;6:6850\u201361.","journal-title":"Oncotarget"},{"key":"7645_CR20","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.canlet.2013.04.022","volume":"336","author":"GH Ha","year":"2013","unstructured":"Ha GH, Kim JL, Breuer EK. Transforming acidic coiled-coil proteins (TACCs) in human cancer. Cancer Lett. 2013;336:24\u201333.","journal-title":"Cancer Lett"},{"key":"7645_CR21","doi-asserted-by":"publisher","first-page":"41885","DOI":"10.18632\/oncotarget.9628","volume":"7","author":"Y Du","year":"2016","unstructured":"Du Y, Liu L, Wang C, Kuang B, Yan S, Zhou A, et al. TACC3 promotes colorectal cancer tumourigenesis and correlates with poor prognosis. Oncotarget. 2016;7:41885\u201397.","journal-title":"Oncotarget"},{"key":"7645_CR22","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.3892\/or.2015.4093","volume":"34","author":"M Yun","year":"2015","unstructured":"Yun M, Rong J, Lin ZR, He YL, Zhang JX, Peng ZW, et al. High expression of transforming acidic coiled coil-containing protein 3 strongly correlates with aggressive characteristics and poor prognosis of gastric cancer. Oncol Rep. 2015;34:1397\u2013405.","journal-title":"Oncol Rep."},{"key":"7645_CR23","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/s41418-023-01140-1","volume":"30","author":"O Saatci","year":"2023","unstructured":"Saatci O, Akbulut O, Cetin M, Sikirzhytski V, Uner M, Lengerli D, et al. Targeting TACC3 represents a novel vulnerability in highly aggressive breast cancers with centrosome amplification. Cell Death Differ. 2023;30:1305\u201319.","journal-title":"Cell Death Differ"},{"key":"7645_CR24","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1158\/1535-7163.MCT-19-0957","volume":"19","author":"O Akbulut","year":"2020","unstructured":"Akbulut O, Lengerli D, Saatci O, Duman E, Seker UOS, Isik A, et al. A highly potent TACC3 inhibitor as a novel anticancer drug candidate. Mol Cancer Ther. 2020;19:1243\u201354.","journal-title":"Mol Cancer Ther"},{"key":"7645_CR25","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1038\/ng.2798","volume":"45","author":"G Guo","year":"2013","unstructured":"Guo G, Sun X, Chen C, Wu S, Huang P, Li Z, et al. Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation. Nat Genet. 2013;45:1459\u201363.","journal-title":"Nat Genet"},{"key":"7645_CR26","doi-asserted-by":"publisher","first-page":"55924","DOI":"10.18632\/oncotarget.10482","volume":"7","author":"R Costa","year":"2016","unstructured":"Costa R, Carneiro BA, Taxter T, Tavora FA, Kalyan A, Pai SA, et al. FGFR3-TACC3 fusion in solid tumors: mini review. Oncotarget. 2016;7:55924\u201338.","journal-title":"Oncotarget"},{"key":"7645_CR27","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.4161\/15384047.2014.961874","volume":"15","author":"L Yuan","year":"2014","unstructured":"Yuan L, Liu ZH, Lin ZR, Xu LH, Zhong Q, Zeng MS. Recurrent FGFR3-TACC3 fusion gene in nasopharyngeal carcinoma. Cancer Biol Ther. 2014;15:1613\u201321.","journal-title":"Cancer Biol Ther"},{"key":"7645_CR28","doi-asserted-by":"crossref","unstructured":"Figueroa JD, Koutros S, Colt JS, Kogevinas M, Garcia-Closas M, Real FX, et al. Modification of occupational exposures on bladder cancer risk by common genetic polymorphisms. J Natl Cancer Inst. 2015;107:djv223.","DOI":"10.1093\/jnci\/djv223"},{"key":"7645_CR29","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/ng.558","volume":"42","author":"LA Kiemeney","year":"2010","unstructured":"Kiemeney LA, Sulem P, Besenbacher S, Vermeulen SH, Sigurdsson A, Thorleifsson G, et al. A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer. Nat Genet. 2010;42:415\u20139.","journal-title":"Nat Genet"},{"key":"7645_CR30","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/s41580-022-00464-z","volume":"23","author":"A Balsalobre","year":"2022","unstructured":"Balsalobre A, Drouin J. Pioneer factors as master regulators of the epigenome and cell fate. Nat Rev Mol Cell Biol. 2022;23:449\u201364.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"7645_CR31","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.cell.2017.06.010","volume":"170","author":"A Tsherniak","year":"2017","unstructured":"Tsherniak A, Vazquez F, Montgomery PG, Weir BA, Kryukov G, Cowley GS, et al. Defining a cancer dependency map. Cell. 2017;170:564\u201376.e16.","journal-title":"Cell"},{"key":"7645_CR32","doi-asserted-by":"publisher","first-page":"6538","DOI":"10.1038\/sj.onc.1209946","volume":"25","author":"M Oeggerli","year":"2006","unstructured":"Oeggerli M, Schraml P, Ruiz C, Bloch M, Novotny H, Mirlacher M, et al. E2F3 is the main target gene of the 6p22 amplicon with high specificity for human bladder cancer. Oncogene. 2006;25:6538\u201343.","journal-title":"Oncogene"},{"key":"7645_CR33","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/nature08822","volume":"463","author":"R Beroukhim","year":"2010","unstructured":"Beroukhim R, Mermel CH, Porter D, Wei G, Raychaudhuri S, Donovan J, et al. The landscape of somatic copy-number alteration across human cancers. Nature. 2010;463:899\u2013905.","journal-title":"Nature"},{"key":"7645_CR34","doi-asserted-by":"publisher","first-page":"D882","DOI":"10.1093\/nar\/gkz1062","volume":"48","author":"Y Luo","year":"2020","unstructured":"Luo Y, Hitz BC, Gabdank I, Hilton JA, Kagda MS, Lam B, et al. New developments on the encyclopedia of DNA elements (ENCODE) data portal. Nucleic Acids Res. 2020;48:D882\u2013D9.","journal-title":"Nucleic Acids Res"},{"key":"7645_CR35","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102:15545\u201350.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7645_CR36","doi-asserted-by":"publisher","first-page":"3349","DOI":"10.21873\/anticanres.15123","volume":"41","author":"MR Akanda","year":"2021","unstructured":"Akanda MR, Park JS, Noh MG, Ha GH, Park YS, Lee JH, et al. TACC3 promotes gastric carcinogenesis by promoting epithelial-mesenchymal transition through the ERK\/Akt\/cyclin D1 signaling pathway. Anticancer Res. 2021;41:3349\u201361.","journal-title":"Anticancer Res"},{"key":"7645_CR37","doi-asserted-by":"publisher","first-page":"3437","DOI":"10.3892\/mmr.2016.5659","volume":"14","author":"X Zhu","year":"2016","unstructured":"Zhu X, Cao Q, Li X, Wang Z. Knockdown of TACC3 inhibits trophoblast cell migration and invasion through the PI3K\/Akt signaling pathway. Mol Med Rep. 2016;14:3437\u201342.","journal-title":"Mol Med Rep"},{"key":"7645_CR38","doi-asserted-by":"crossref","unstructured":"Ryan EL, Shelford J, Massam-Wu T, Bayliss R, Royle SJ. Defining endogenous TACC3-chTOG-clathrin-GTSE1 interactions at the mitotic spindle using induced relocalization. J Cell Sci. 2021;134:jcs255794.","DOI":"10.1242\/jcs.255794"},{"key":"7645_CR39","doi-asserted-by":"publisher","first-page":"114874","DOI":"10.1016\/j.ejmech.2022.114874","volume":"244","author":"W Zhao","year":"2022","unstructured":"Zhao W, Sun X, Shi L, Cai SZ, Ma ZR. Discovery of novel analogs of KHS101 as transforming acidic coiled coil containing protein 3 (TACC3) inhibitors for the treatment of glioblastoma. Eur J Med Chem. 2022;244:114874.","journal-title":"Eur J Med Chem"},{"key":"7645_CR40","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/0092-8674(93)90663-B","volume":"72","author":"B Amati","year":"1993","unstructured":"Amati B, Brooks MW, Levy N, Littlewood TD, Evan GI, Land H. Oncogenic activity of the c-Myc protein requires dimerization with Max. Cell. 1993;72:233\u201345.","journal-title":"Cell"},{"key":"7645_CR41","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/pro.3978","volume":"30","author":"R Oughtred","year":"2021","unstructured":"Oughtred R, Rust J, Chang C, Breitkreutz BJ, Stark C, Willems A, et al. The BioGRID database: a comprehensive biomedical resource of curated protein, genetic, and chemical interactions. Protein Sci. 2021;30:187\u2013200.","journal-title":"Protein Sci"},{"key":"7645_CR42","doi-asserted-by":"publisher","first-page":"D529","DOI":"10.1093\/nar\/gky1079","volume":"47","author":"R Oughtred","year":"2019","unstructured":"Oughtred R, Stark C, Breitkreutz BJ, Rust J, Boucher L, Chang C, et al. The BioGRID interaction database: 2019 update. Nucleic Acids Res. 2019;47:D529\u2013D41.","journal-title":"Nucleic Acids Res"},{"key":"7645_CR43","doi-asserted-by":"publisher","first-page":"10826","DOI":"10.1128\/MCB.24.24.10826-10834.2004","volume":"24","author":"JH Patel","year":"2004","unstructured":"Patel JH, Du Y, Ard PG, Phillips C, Carella B, Chen CJ, et al. The c-MYC oncoprotein is a substrate of the acetyltransferases hGCN5\/PCAF and TIP60. Mol Cell Biol. 2004;24:10826\u201334.","journal-title":"Mol Cell Biol"},{"key":"7645_CR44","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1083\/jcb.200809167","volume":"185","author":"J Yuan","year":"2009","unstructured":"Yuan J, Minter-Dykhouse K, Lou Z. A c-Myc-SIRT1 feedback loop regulates cell growth and transformation. J Cell Biol. 2009;185:203\u201311.","journal-title":"J Cell Biol"},{"key":"7645_CR45","doi-asserted-by":"publisher","first-page":"10220","DOI":"10.1128\/MCB.25.23.10220-10234.2005","volume":"25","author":"F Faiola","year":"2005","unstructured":"Faiola F, Liu X, Lo S, Pan S, Zhang K, Lymar E, et al. Dual regulation of c-Myc by p300 via acetylation-dependent control of Myc protein turnover and coactivation of Myc-induced transcription. Mol Cell Biol. 2005;25:10220\u201334.","journal-title":"Mol Cell Biol"},{"key":"7645_CR46","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/sj.embor.embor821","volume":"4","author":"J Vervoorts","year":"2003","unstructured":"Vervoorts J, Luscher-Firzlaff JM, Rottmann S, Lilischkis R, Walsemann G, Dohmann K, et al. Stimulation of c-MYC transcriptional activity and acetylation by recruitment of the cofactor CBP. EMBO Rep. 2003;4:484\u201390.","journal-title":"EMBO Rep."},{"key":"7645_CR47","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1038\/s42255-024-01037-4","volume":"6","author":"J Wang","year":"2024","unstructured":"Wang J, Yang Y, Shao F, Meng Y, Guo D, He J, et al. Acetate reprogrammes tumour metabolism and promotes PD-L1 expression and immune evasion by upregulating c-Myc. Nat Metab. 2024;6:914\u201332.","journal-title":"Nat Metab"},{"key":"7645_CR48","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41568-019-0143-7","volume":"19","author":"LN Kent","year":"2019","unstructured":"Kent LN, Leone G. The broken cycle: E2F dysfunction in cancer. Nat Rev Cancer. 2019;19:326\u201338.","journal-title":"Nat Rev Cancer"},{"key":"7645_CR49","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.cmet.2020.12.015","volume":"33","author":"D Xu","year":"2021","unstructured":"Xu D, Shao F, Bian X, Meng Y, Liang T, Lu Z. The evolving landscape of noncanonical functions of metabolic enzymes in cancer and other pathologies. Cell Metab. 2021;33:33\u201350.","journal-title":"Cell Metab"},{"key":"7645_CR50","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.molcel.2012.01.001","volume":"45","author":"X Gao","year":"2012","unstructured":"Gao X, Wang H, Yang JJ, Liu X, Liu ZR. Pyruvate kinase M2 regulates gene transcription by acting as a protein kinase. Mol Cell. 2012;45:598\u2013609.","journal-title":"Mol Cell"},{"key":"7645_CR51","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.cell.2012.07.018","volume":"150","author":"W Yang","year":"2012","unstructured":"Yang W, Xia Y, Hawke D, Li X, Liang J, Xing D, et al. PKM2 phosphorylates histone H3 and promotes gene transcription and tumorigenesis. Cell. 2012;150:685\u201396.","journal-title":"Cell"},{"key":"7645_CR52","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/nature10598","volume":"480","author":"W Yang","year":"2011","unstructured":"Yang W, Xia Y, Ji H, Zheng Y, Liang J, Huang W, et al. Nuclear PKM2 regulates beta-catenin transactivation upon EGFR activation. Nature. 2011;480:118\u201322.","journal-title":"Nature"},{"key":"7645_CR53","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1038\/ncb2629","volume":"14","author":"W Yang","year":"2012","unstructured":"Yang W, Zheng Y, Xia Y, Ji H, Chen X, Guo F, et al. ERK1\/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect. Nat Cell Biol. 2012;14:1295\u2013304.","journal-title":"Nat Cell Biol"},{"key":"7645_CR54","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.cell.2011.03.054","volume":"145","author":"W Luo","year":"2011","unstructured":"Luo W, Hu H, Chang R, Zhong J, Knabel M, O\u2019Meally R, et al. Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1. Cell. 2011;145:732\u201344.","journal-title":"Cell"},{"key":"7645_CR55","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/S1097-2765(03)00193-X","volume":"11","author":"N von der Lehr","year":"2003","unstructured":"von der Lehr N, Johansson S, Wu S, Bahram F, Castell A, Cetinkaya C, et al. The F-box protein Skp2 participates in c-Myc proteosomal degradation and acts as a cofactor for c-Myc-regulated transcription. Mol Cell. 2003;11:1189\u2013200.","journal-title":"Mol Cell"},{"key":"7645_CR56","doi-asserted-by":"publisher","first-page":"9085","DOI":"10.1073\/pnas.0402770101","volume":"101","author":"M Welcker","year":"2004","unstructured":"Welcker M, Orian A, Jin J, Grim JE, Harper JW, Eisenman RN, et al. The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation. Proc Natl Acad Sci USA. 2004;101:9085\u201390.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7645_CR57","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1038\/onc.2012.144","volume":"32","author":"I Paul","year":"2013","unstructured":"Paul I, Ahmed SF, Bhowmik A, Deb S, Ghosh MK. The ubiquitin ligase CHIP regulates c-Myc stability and transcriptional activity. Oncogene. 2013;32:1284\u201395.","journal-title":"Oncogene"},{"key":"7645_CR58","doi-asserted-by":"publisher","first-page":"16202","DOI":"10.1074\/jbc.M115.645978","volume":"290","author":"Z Mei","year":"2015","unstructured":"Mei Z, Zhang D, Hu B, Wang J, Shen X, Xiao W. FBXO32 Targets c-Myc for proteasomal degradation and inhibits c-Myc activity. J Biol Chem. 2015;290:16202\u201314.","journal-title":"J Biol Chem"},{"key":"7645_CR59","doi-asserted-by":"publisher","first-page":"3957","DOI":"10.1038\/onc.2014.327","volume":"34","author":"J Pan","year":"2015","unstructured":"Pan J, Deng Q, Jiang C, Wang X, Niu T, Li H, et al. USP37 directly deubiquitinates and stabilizes c-Myc in lung cancer. Oncogene. 2015;34:3957\u201367.","journal-title":"Oncogene"},{"key":"7645_CR60","doi-asserted-by":"publisher","first-page":"6417","DOI":"10.1038\/s41388-021-02031-w","volume":"40","author":"R Tu","year":"2021","unstructured":"Tu R, Kang W, Yang M, Wang L, Bao Q, Chen Z, et al. USP29 coordinates MYC and HIF1alpha stabilization to promote tumor metabolism and progression. Oncogene. 2021;40:6417\u201329.","journal-title":"Oncogene"},{"key":"7645_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06446-7","volume":"15","author":"M Li","year":"2024","unstructured":"Li M, Yu J, Ju L, Wang Y, Jin W, Zhang R, et al. USP43 stabilizes c-Myc to promote glycolysis and metastasis in bladder cancer. Cell Death Dis. 2024;15:44.","journal-title":"Cell Death Dis"},{"key":"7645_CR62","doi-asserted-by":"publisher","first-page":"D174","DOI":"10.1093\/nar\/gkad1059","volume":"52","author":"I Rauluseviciute","year":"2024","unstructured":"Rauluseviciute I, Riudavets-Puig R, Blanc-Mathieu R, Castro-Mondragon JA, Ferenc K, Kumar V, et al. JASPAR 2024: 20th anniversary of the open-access database of transcription factor binding profiles. Nucleic Acids Res. 2024;52:D174\u2013D82.","journal-title":"Nucleic Acids Res"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07645-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07645-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07645-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T16:02:39Z","timestamp":1744905759000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07645-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,17]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7645"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-07645-6","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,17]]},"assertion":[{"value":"6 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Our manuscript does not involve the use of human samples. All animal studies were approved and supervised by the Animal Ethics Committee of Guangdong Provincial People\u2019s Hospital (KY-Z-2021-351-02) and performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"311"}}